deltatrials
Unknown NA INTERVENTIONAL 2-arm NCT02487628

Evaluation of HQ® Matrix Soft Tissue Mesh for the Treatment of Inguinal Hernia

Multi-center, Randomized, Active-controlled, Single-blind, Parallel Two-group Trial of HQ® Matrix Soft Tissue Mesh and ULTRAPRO® Partially Absorbable Lightweight Mesh for the Treatment of Inguinal Hernia

Sponsor: Zhejiang Xingyue Biotechnology Co., Ltd.

Conditions Inguinal Hernia
Interventions HQ® Matrix Soft Tissue Mesh ULTRAPRO® Partially Absorbable Lightweight Mesh
Updated 6 times since 2017 Last updated: Jun 29, 2015 Started: Nov 30, 2014 Primary completion: Jun 30, 2016 Completion: Dec 31, 2016
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Inguinal Hernia, this trial is ongoing. The trial is conducted by Zhejiang Xingyue Biotechnology Co., Ltd. and has accumulated 6 data snapshots since 2014. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

~Jan 2017 – ~Jul 2017 · 6 months · monthly snapshotRecruiting~Jul 2017 – ~Jun 2018 · 11 months · monthly snapshotUnknown Status~Jun 2018 – ~Jan 2021 · 31 months · monthly snapshotUnknown Status~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotUnknown Status~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotUnknown~Sep 2024 – present · 24 months · monthly snapshotUnknown

Change History

6 versions recorded

  1. Sep 2024 — Present [monthly]

    Unknown NA

  2. Jul 2024 — Sep 2024 [monthly]

    Unknown NA

    Status: Unknown Status → Unknown

  3. Jan 2021 — Jul 2024 [monthly]

    Unknown Status NA

  4. Jun 2018 — Jan 2021 [monthly]

    Unknown Status NA

  5. Jul 2017 — Jun 2018 [monthly]

    Unknown Status NA

    Status: Recruiting → Unknown Status

▶ Show 1 earlier version

  1. Jan 2017 — Jul 2017 [monthly]

    Recruiting NA

    First recorded

Nov 2014

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Zhejiang Xingyue Biotechnology Co., Ltd.
Data source: Zhejiang Xingyue Biotechnology Co., Ltd.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations